Skip to main content

Table 1 Baseline parameters of Fluocinolone Acetonide implant treated eyes

From: Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting

Parameter

Value

Visual Acuity (ETDRS letters)

Range (2–85), Mean (50.7)

Central Retinal Thickness (Micrometers)

Range (373–1052) .Mean (631)

Duration of DMO(Months)

Range (9-47). Mean (26.2)

Foveal eversion

21

Pseudophakia

22

Eyes with one co-existing pathology

ERM(n = 11)

VMT(n = 2)

Glaucoma/Ocular hypertension (n = 4)

NVD n = 1

NVE n = 1

Eyes with >1 co-existing pathologies

3

Eyes on IOP lowering drugs

4

Eyes with prior macular laser only

15

Eyes with prior vitrectomy for DMO/ERM

1

Eyes with prior intravitreal therapy

Ranibizumab only– n = 11

Bevacizumab only n = 2

Rani and Beva n = 3

Triamcinolone n = 6

Eyes with prior PRP

9